A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in several types of malignancies, leading https://getsocialselling.com/story7485729/mini-antibodies-revive-p53-new-potential-hope-for-tumor-treatment